The Dementia Risk Index functional Test (DRIfT) measures five key biomarkers strongly linked to cognitive function, brain ageing and dementia risk: Omega-3 essential fats that help build and protect brain cells Vitamin D supports brain, immune and cognitive health Homocysteine a marker linked to B vitamin status and increased dementia risk when elevated HbA1c measures average blood sugar balance over time Glutathione Index reflects antioxidant protection and oxidative stress in the brain and body Together, these create your personalised DRIfT score, helping identify areas that may need attention to support long-term brain health
In this review, we redefine the scope by focusing specifically on microbiome-sensitive and green smart nanomaterials, highlighting their mechanistic interactions with chronic wound microenvironments
Benefits PT-141 is believed to help with: Braincentered desire support: By acting on melanocortin receptors in the hypothalamus, PT141 can improve subjective desire, arousal, and satisfactionaddressing the want to rather than just the can. Ondemand flexibility: Typically dosed as a subcutaneous injection about 45 minutes before anticipated activity, allowing clients to plan special moments without daily medication. Hormonesparing option: PT141 does not require systemic estrogen or testosterone and can be attractive for clients who are not candidates for or do not wish to use hormone therapy. Potential for both women and men: FDA approval is specific to premenopausal women with HSDD, but emerging clinical practice and research describe benefits in broader female populations and in men with libido or erectile issues, always offlabel and carefully consented.
Clinical studies have demonstrated its effectiveness in inducing significant weight loss
